Pharma teams need more than a snapshot of who a patient is. They need to understand how disease, health, and treatment experiences unfold over time, including what happens between clinical encounters. By combining traditional real-world data sources such as EHR and claims with direct, ongoing engagement with patients, teams can collect the symptoms, experiences, behaviors, and context that are often missing from the clinical record. Together, these data create a more longitudinal and complete view of how patients present, progress, and respond to treatment in everyday life.
Join senior executives for a 60-minute live discussion on how bringing these data together earlier and more strategically can improve evidence generation and decision-making across the product lifecycle. The panel will explore how going directly to patients can help teams identify meaningful changes in disease and treatment experience, test assumptions against real-world practice, and better understand the populations and moments that matter. The discussion will consider how these approaches can inform decisions across medical affairs, patient insights, RWE, access, and commercialization.
Gain real examples and true insights on:
• How patient registry, EHR, and claims data can be used to validate assumptions about target populations against how patients actually present and progress in real-world practice.
• How mapping real-world patient pathways helps identify the right populations and touchpoints, strengthening evidence relevance and generalizability across the product lifecycle.
• Where encounter-based datasets fall short in capturing meaningful patient and treatment transitions, and why this matters for teams making evidence-based decisions.
Sign up for the free live event now and submit your questions to the panel today — this is your chance to get expert answers to the challenges you're facing. Can't make it live? Register anyway to receive the full recording straight to your inbox.
